The World Health Organization (WHO) has sought more information from Bharat Biotech on its emergency use listing (EUL) application for Covaxin, according to the documents on the global health agency's website.
The documents showed Bharat Biotech submitted Expression of Interest with the WHO for EUL on April 19.
Bharat Biotech will hold a pre-submission meeting with WHO in May or June. After the meeting, there are further three stages where the application will be reviewed before the approval.
The WHO’s EUL opens the door for countries to expedite their own regulatory approval processes to import and administer the vaccine. It also enables UNICEF